TROP2-expressing solid tumors

Clinical trials for TROP2-expressing solid tumors explained in plain language.

Never miss a new study

Get alerted when new TROP2-expressing solid tumors trials appear

Sign up with your email to follow new studies for TROP2-expressing solid tumors, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Off-the-Shelf cell therapy takes on Hard-to-Treat cancers

Disease control Recruiting now

This study tests a new treatment called EB-NK-301, which uses specially engineered immune cells (CAR NK cells) to target a protein called TROP2 found on many solid tumors. The trial enrolls 60 adults with advanced or metastatic cancers that have not responded to standard treatmen…

Matched conditions: TROP2-EXPRESSING SOLID TUMORS

Phase 1/2 • Sponsor: Beijing Biotech • Aim: Disease control

Last updated Jun 27, 2026 12:32 UTC

TROP2-expressing solid tumors

Get alerted when new TROP2-expressing solid tumors trials appear

Off-the-Shelf cell therapy takes on Hard-to-Treat cancers